HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

XUANZHUBIO-B

17.060

-0.840-4.69%

Volume:792.51K

Turnover:13.75M

Market Cap:8.84B

PE:-27.88

High:17.680

Open:17.500

Low:16.780

Close:17.900

52wk High:96.900

52wk Low:16.780

Shares:518.00M

HK Float Shares:517.95M

Volume Ratio:0.32

T/O Rate:0.15%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.612

ROE:-21.10%

ROA:-10.28%

PB:5.59

PE(LYR):-27.88

PS:147.83

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Xuanzhu Biopharmaceutical seeks bylaw changes to scrap supervisory committee, shift oversight to audit committee

Registration Open for "Zhihui Financial 2026 Summer Roadshow Conference"

Xuanzhu Biopharma Converts 357.25 Million Unlisted Shares into H Shares, Lifting Issued Share Base by 68.97%

Bulletin Express

Xuanzhu Biopharmaceutical Completes H-Share Full Circulation, Converts 357.25 Million Unlisted Shares

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02575"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02575","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02575\",,,,,undefined,":{"symbol":"02575","market":"HK","secType":"STK","nameCN":"XUANZHUBIO-B","latestPrice":17.06,"timestamp":1779782901159,"preClose":17.9,"halted":0,"volume":792506,"delay":0,"changeRate":-0.04692737430167598,"floatShares":517947790,"shares":518000000,"eps":-0.6119662124571974,"marketStatus":"Closed","change":-0.84,"latestTime":"05-26 16:08:21","open":17.5,"high":17.68,"low":16.78,"amount":13752734,"amplitude":0.050279,"askPrice":17.45,"askSize":500,"bidPrice":17.04,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.6061929463019408,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1779845400000},"marketStatusCode":5,"adr":0,"listingDate":1760457600000,"exchange":"SEHK","adjPreClose":17.9,"openAndCloseTimeList":[[1779759000000,1779768000000],[1779771600000,1779782400000]],"volumeRatio":0.316922,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02575\",,,,,undefined,":{"symbol":"02575","floatShares":517947790,"roa":"-10.28%","roe":"-21.10%","lyrEps":-0.611966,"volumeRatio":0.316922,"shares":518000000,"dividePrice":0,"high":17.68,"amplitude":0.050279,"preClose":17.9,"low":16.78,"week52Low":16.78,"pbRate":"5.59","psRate":"147.83","week52High":96.9,"institutionHeld":0,"latestPrice":17.06,"eps":-0.6119662124571974,"divideRate":0,"volume":792506,"delay":0,"ttmEps":-0.6061929463019408,"open":17.5,"prevYearClose":70.5,"prevWeekClose":17.9,"prevMonthClose":21.56,"prevQuarterClose":29.32,"fiveDayClose":19.31,"twentyDayClose":24.82,"sixtyDayClose":63.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02575\",params:#limit:5,,,undefined,":[{"date":"2026-03-30","symbol":"02575","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02575\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02575\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02575\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02575","date":"2026-05-22","current":-28.142341,"percent":0.910959,"low":-70.039607,"twenty":-57.162996,"median":-53.511235,"eighty":-40.250137,"high":-22.444691,"avg":-49.36505,"sd":10.086583,"marketCap":9271265441},"quantilePoints":[{"date":"2025-10-17","current":-28.93414,"twenty":-27.261252,"median":-24.751919,"eighty":-23.367582,"marketCap":17558430081},{"date":"2025-10-24","current":-50.850969,"twenty":-50.816841,"median":-33.923646,"eighty":-26.424807,"marketCap":30869688284},{"date":"2025-10-31","current":-54.182971,"twenty":-53.663557,"median":-50.808309,"eighty":-28.95487,"marketCap":32941479444},{"date":"2025-11-07","current":-55.367666,"twenty":-55.639174,"median":-53.630543,"eighty":-30.992132,"marketCap":33640708960},{"date":"2025-11-14","current":-54.36116,"twenty":-55.639174,"median":-54.1994,"eighty":-41.200731,"marketCap":33122761170},{"date":"2025-11-21","current":-53.748657,"twenty":-55.319259,"median":-54.136108,"eighty":-50.782713,"marketCap":32734300328},{"date":"2025-11-28","current":-53.384655,"twenty":-55.070724,"median":-54.15954,"eighty":-50.923112,"marketCap":32630710770},{"date":"2025-12-05","current":-54.773392,"twenty":-55.070724,"median":-54.21583,"eighty":-51.627953,"marketCap":33537119402},{"date":"2025-12-12","current":-70.039607,"twenty":-55.665823,"median":-54.261136,"eighty":-53.311356,"marketCap":42963769180},{"date":"2025-12-19","current":-60.019152,"twenty":-56.570931,"median":-54.488669,"eighty":-53.433833,"marketCap":36903780037},{"date":"2025-12-24","current":-59.160975,"twenty":-59.157371,"median":-54.549256,"eighty":-53.581365,"marketCap":36489421805},{"date":"2026-01-02","current":-54.537602,"twenty":-59.158272,"median":-54.690337,"eighty":-53.655303,"marketCap":33770195908},{"date":"2026-01-09","current":-52.983682,"twenty":-59.049917,"median":-54.49123,"eighty":-52.274882,"marketCap":32889684665},{"date":"2026-01-16","current":-58.758617,"twenty":-58.846722,"median":-54.572443,"eighty":-53.169291,"marketCap":36593011363},{"date":"2026-01-23","current":-52.071916,"twenty":-58.705513,"median":-54.4959,"eighty":-52.506318,"marketCap":32397634264},{"date":"2026-01-30","current":-53.326607,"twenty":-57.909955,"median":-54.48995,"eighty":-52.506318,"marketCap":33329940286},{"date":"2026-02-06","current":-57.283358,"twenty":-57.848985,"median":-54.4959,"eighty":-52.506318,"marketCap":35893781847},{"date":"2026-02-13","current":-51.942748,"twenty":-58.578655,"median":-54.516751,"eighty":-52.506318,"marketCap":32734300328},{"date":"2026-02-20","current":-51.153455,"twenty":-58.517685,"median":-54.493565,"eighty":-52.321662,"marketCap":32190455148},{"date":"2026-02-27","current":-53.732962,"twenty":-57.403185,"median":-54.403912,"eighty":-52.138331,"marketCap":34184554140},{"date":"2026-03-06","current":-41.037619,"twenty":-57.295346,"median":-54.261136,"eighty":-51.687579,"marketCap":25897389500},{"date":"2026-03-13","current":-40.849477,"twenty":-57.283358,"median":-54.21583,"eighty":-50.904735,"marketCap":25897389500},{"date":"2026-03-20","current":-35.26408,"twenty":-56.603099,"median":-54.112473,"eighty":-49.228933,"marketCap":22271754970},{"date":"2026-03-27","current":-28.858752,"twenty":-56.47148,"median":-53.935449,"eighty":-43.741043,"marketCap":18179967429},{"date":"2026-04-02","current":-57.594339,"twenty":-56.497804,"median":-53.833069,"eighty":-43.169536,"marketCap":16087458357},{"date":"2026-04-10","current":-59.545661,"twenty":-57.25627,"median":-53.970491,"eighty":-43.400861,"marketCap":16760790484},{"date":"2026-04-17","current":-61.727863,"twenty":-57.517877,"median":-54.136108,"eighty":-43.645588,"marketCap":17382327832},{"date":"2026-04-24","current":-45.649544,"twenty":-57.360049,"median":-54.047185,"eighty":-44.053945,"marketCap":12855464147},{"date":"2026-04-30","current":-39.643505,"twenty":-57.292948,"median":-53.884259,"eighty":-43.829171,"marketCap":11166954352},{"date":"2026-05-08","current":-39.029961,"twenty":-57.269814,"median":-53.732962,"eighty":-42.509315,"marketCap":11032287927},{"date":"2026-05-15","current":-34.724128,"twenty":-57.211578,"median":-53.651177,"eighty":-40.906347,"marketCap":9841008010},{"date":"2026-05-22","current":-32.788719,"twenty":-57.162996,"median":-53.511235,"eighty":-40.250137,"marketCap":9271265441}],"updateTime":1779791033439},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02575\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638518902","title":"Xuanzhu Biopharmaceutical seeks bylaw changes to scrap supervisory committee, shift oversight to audit committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2638518902","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638518902?lang=en_us&edition=fundamental","pubTime":"2026-05-26 17:46","pubTimestamp":1779788807,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical proposed bylaw amendments to abolish its supervisory committee, shifting oversight to an audit committee.Board structure would add an employee representative director as a non-executive, elected via an employee representative meeting.Executive director Li Jia Kui’s resignation would take effect upon that appointment, filling the vacancy created by his departure.Post-change board would comprise 2 executive directors, 4 non-executive directors, 3 independent non-executive directors.Shareholders will vote on the amendments at the June 18, 2026 AGM via special resolution.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xuanzhu Biopharmaceutical Co. Ltd. published the original content used to generate this news brie","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL62ZvLc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","02575","BK1515","00460","BK1191","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100532115","title":"Registration Open for \"Zhihui Financial 2026 Summer Roadshow Conference\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1100532115","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100532115?lang=en_us&edition=fundamental","pubTime":"2026-05-18 10:47","pubTimestamp":1779072449,"startTime":"0","endTime":"0","summary":"In the first half of 2026, the Hong Kong capital market is experiencing a long-awaited period of heightened activity. Since the second quarter, the Hong Kong market has been on a sustained recovery...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1251922891.USD","02675","03881","02623","BK1149","BK1144","LU0359201885.HKD","BK1207","02706","02411","LU0702159699.USD","BK1183","BK1240","HK0001040143.USD","BK1147","BK1155","BK4588","03317","LU0264606111.USD","01907","00290","01378","02575","BK1594","SG9999014674.SGD","BK1100","00650","02726","LU0572939691.SGD","06682","02729","BK1116","LU1719994722.HKD","02650","06938","LU0572940350.SGD","SG9999001093.SGD","00363","LU0345781412.USD","VXUS","02142","LU1813983027.USD","LU0287142896.SGD","00826","03858","08299","BK1617","BK1500","BK1583","BK1163","LU0630314457.HKD","BK1249","01333","BK1161","LU0173614495.USD","01300","BK1230","LU0588546209.SGD","BK1175","BK1578","BK1162","LU0359202008.SGD","BK1539","BK4585","HK0001040168.HKD","BK1229","02228","01384","BK1117","02685","BK1574","LU2039709279.SGD","06651","BK1129","BK1109","06636","LU0345780950.USD","00305","BK1198","02652","06051","LU1328277881.USD","00400","LU1224709979.USD","BK1205","BK1191","LU0737861699.HKD","BK1506","LU1023057109.AUD","BK1169","LU0359201612.USD","06090","02526","LU0314109678.HKD","LU1303224171.USD","BK1190","BK1132","02670","02655","09696","01021","01396","BK1141","LU1770034418.SGD","BK1225","BK1142","BK1110","LU0469268626.HKD","LU1166156734.SGD","BK1592","02889","BK1238","02565","BK1171","BK1613","02659","BK1258","LU0307460666.USD","BK1541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175245965","title":"Xuanzhu Biopharma Converts 357.25 Million Unlisted Shares into H Shares, Lifting Issued Share Base by 68.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=1175245965","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175245965?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:02","pubTimestamp":1778583763,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical Co., Ltd. (Xuanzhu Biopharma) has completed the conversion of 357.25 million unlisted shares into the same number of H shares, according to its Next Day Disclosure Return...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112216216","title":"Xuanzhu Biopharmaceutical Completes H-Share Full Circulation, Converts 357.25 Million Unlisted Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1112216216","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112216216?lang=en_us&edition=fundamental","pubTime":"2026-05-12 17:03","pubTimestamp":1778576591,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical Co., Ltd. announced on 12 May 2026 that it has finalised its H-share full-circulation programme, converting 357.25 million unlisted domestic shares into H shares. The newly...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":22,"pageCount":1,"totalSize":85,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02575\",params:#limit:6,delay:false,,,undefined,":[]}}